Dicerna Pharmaceuticals' Series A - II Round

Dicerna Pharmaceuticals raised a round of funding on July 11, 2008.

Dicerna Pharmaceuticals is a pharmaceutical company developing RNA interference (RNAi)-based therapeutics against genetically-defined targets in multiple disease areas, including cancer. Dicerna's the…

Articles about Dicerna Pharmaceuticals' Series A - II Round: